145 related articles for article (PubMed ID: 10619218)
1. Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service.
Keks NA; Altson K; Hope J; Krapivensky N; Culhane C; Tanaghow A; Doherty P; Bootle A
Aust N Z J Psychiatry; 1999 Dec; 33(6):896-901. PubMed ID: 10619218
[TBL] [Abstract][Full Text] [Related]
2. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
Bret P; Bonnet F; Bret MC; Jaffré A
Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.
Gianfrancesco FD; Grogg AL; Mahmoud RA; Wang RH; Nasrallah HA
J Clin Psychiatry; 2002 Oct; 63(10):920-30. PubMed ID: 12416602
[TBL] [Abstract][Full Text] [Related]
4. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
5. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
Guille C; Sachs GS; Ghaemi SN
J Clin Psychiatry; 2000 Sep; 61(9):638-42. PubMed ID: 11030483
[TBL] [Abstract][Full Text] [Related]
6. Comparison of risperidone and olanzapine as used under "real-world" conditions in a state psychiatric hospital.
Advokat C; Dixon D; Schneider J; Comaty JE
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):487-95. PubMed ID: 15093956
[TBL] [Abstract][Full Text] [Related]
7. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
[TBL] [Abstract][Full Text] [Related]
8. Service use and costs of treating schizophrenia with atypical antipsychotics.
Lewis M; McCrone P; Frangou S
J Clin Psychiatry; 2001 Oct; 62(10):749-56. PubMed ID: 11816863
[TBL] [Abstract][Full Text] [Related]
9. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
[TBL] [Abstract][Full Text] [Related]
10. Prescribing second-generation antipsychotics and the evolving standard of care in Italy.
Barbui C; Danese A; Guaiana G; Mapelli L; Miele L; Monzani E; Percudani M;
Pharmacopsychiatry; 2002 Nov; 35(6):239-43. PubMed ID: 12518273
[TBL] [Abstract][Full Text] [Related]
11. The effects of risperidone and olanzapine on the indications for clozapine.
Ganguli R; Brar JS
Psychopharmacol Bull; 1998; 34(1):83-7. PubMed ID: 9564203
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA
Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192
[TBL] [Abstract][Full Text] [Related]
13. Risperidone and olanzapine in adults with intellectual disability: a clinical naturalistic study.
Bokszanska A; Martin G; Vanstraelen M; Holt G; Bouras N; Taylor D
Int Clin Psychopharmacol; 2003 Sep; 18(5):285-91. PubMed ID: 12920389
[TBL] [Abstract][Full Text] [Related]
14. New antipsychotic drugs produce better outcomes.
Healthc Benchmarks; 1997 Oct; 4(10):142-4. PubMed ID: 10173374
[No Abstract] [Full Text] [Related]
15. Priapism associated with conventional and atypical antipsychotic medications: a review.
Compton MT; Miller AH
J Clin Psychiatry; 2001 May; 62(5):362-6. PubMed ID: 11411819
[TBL] [Abstract][Full Text] [Related]
16. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients.
Scheltema Beduin AA; Swets M; Machielsen M; Korver N;
J Clin Psychiatry; 2012 Nov; 73(11):1395-402. PubMed ID: 23218156
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
[TBL] [Abstract][Full Text] [Related]
18. Weight gain and antipsychotic medications.
Aquila R; Emanuel M
J Clin Psychiatry; 1999 May; 60(5):336-7. PubMed ID: 10362443
[No Abstract] [Full Text] [Related]
19. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine-induced neutropenia in patients with history of clozapine treatment: two case reports from a state psychiatric institution.
Teter CJ; Early JJ; Frachtling RJ
J Clin Psychiatry; 2000 Nov; 61(11):872-3. PubMed ID: 11105743
[No Abstract] [Full Text] [Related]
[Next] [New Search]
